Pregled bibliografske jedinice broj: 339324
Time course of amyloid beta pathology in streptozotocin-rat model of sporadic Alzheimer's disease.
Time course of amyloid beta pathology in streptozotocin-rat model of sporadic Alzheimer's disease. // Parkinsonism & Related Disorders. Supplement 2 / Calne, Donald B (ur.).
Amsterdam: Elsevier, 2007. str. S129-S129 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 339324 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Time course of amyloid beta pathology in streptozotocin-rat model of sporadic Alzheimer's disease.
Autori
Salkovic-Petrisic, Melita ; Osmanovic, Jelena ; Hoyer, Siegfried ; Riederer, Peter
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Parkinsonism & Related Disorders. Supplement 2
/ Calne, Donald B - Amsterdam : Elsevier, 2007, S129-S129
Skup
XVII WFN World Congress on Parkinson’ s Disease and Related Disorders
Mjesto i datum
Amsterdam, Nizozemska, 9-13 prosinac
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Streptozotocin rat model; Sporadic Alzheimer's Disease; Beta-Amyloid
Sažetak
Objectives: Modelling of Alzheimer’ s disease usually involves transgenic mice models which represent early onset familiar type of Alzheimer’ s disease (AD) for which pathological assemblies of amyloid beta (Aβ ) are thought to be the primary cause. Streptozotocin-intracerebroventricularly (STZ-icv) treated rats have been recognized as an experimental model for more frequent sporadic type of AD (sAD) which share with humans similarities of impaired brain insulin receptor (IR) signalling. We aimed to investigate the six month long time course of possible pathological changes of beta amyloid following the brain damage induced by STZ-icv treatment in rats. Methods. Male Wistar rats (3-4 month old) were sacrifice one, three or six months after STZ-icv treatment (1-3 mg/kg). Congo red staining and Aβ 1-42 immunohistochemistry analyses were done on fixative-perfused, paraffin-embedded brain sections. Cognitive functions were tested in Morris Water Maze Test. Cruscal-Walles ANOVA and Mann-Whitney U test (P<0.05) were used. Results. One month after STZ-icv treatment no changes of Aβ were observed, while congophilic Aβ aggregates in meningeal capillaries which gave autoflorescence green light in cross-polarized light, and intracellular Aβ 1-42 accumulation in hippocampus/cerebral cortex were found after three months. In these regions Aβ 1-42 signal revealed primitive plaques formation six months following the STZ-icv treatment. Cognitive deficits, observed already after one month, persisted along the experiment. Conclusions. Results demonstrate the sequence of Aβ pathology development starting in capillaries, moving to intracellular and finally extracellular accumulation and primitive plaque formation with the duration of period after the brain damage induced by betycytotoxic drug streptozotocin. Since STZ-icv treatment induces insulin resistant brain state (IRBS) in rats, these results provide evidence that IRBS could be a pathological core in generation of sAD preceding and triggering Aβ plaque development and tau protein hyperphosphorylation.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080003-0020 - Mozak, eksperimentalni i cerebralni dijabetes i kognitivni i drugi poremećaji (Šalković-Petrišić, Melita, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE